chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1 of 5 pts who had a reaction following vax; pt exp a rash & numbness of the lips;
sick; Initial information received on 26-Oct-2020 regarding an unsolicited valid non-serious case from a consumer (patient) via social media.  This case is linked to case ID: 2020SA302080 (same source).  This case involves a patient of an unknown demographics who got sick (illness), after receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatments, vaccinations, concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient got sick (illness) (non-serious event) (unknown latency) following the administration of INFLUENZA VACCINE and stated that not taking it anymore.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information on the batch number for this case.
Ache; Right arm sore at injection site; Lump/pain in right arm pit starting two days after shot and continuing for a week after the shot; Tired; This is a spontaneous report from a contactable Consumer. A 57-year-old non-pregnant female patient received BNT162B2(PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot/batch number: EN6206), via an unspecified route of administration in the right arm on 10Mar2021 at 01:15PM (at the age of 57-years-old) as a single dose for COVID-19 Immunisation. The patient was allergic to shellfish, latex, vicodin and percoset. concomitant medications were not included. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to the vaccine and she did not receive any other vaccines within 2 weeks post vaccination. On 10Mar2021 at 08:00 PM the patient experienced Right arm sore at injection site, tired and achy for 3 days after shot, lump/pain in right arm pit starting two days after shot and continuing for a week after the shot (as reported). It was unknown if the patient received the treatment for the events. The clinical outcome of the events we unknown. No follow-up attempts are needed. No further information is expected.
Information has been received from a physician concerning a 7 year old female who on 16-NOV-1999 was vaccinated with a dose of Varivax. On 11-JUN-2006 the patient developed a breakthrough case of chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
This spontaneous case, received on 10-Oct-2017, reported by a pharmacist, concerns 69-year-old female patient. On 09-Oct-2017, the patient received a second dose of FLUVIRIN (dose: 0.5ml, route of administration: intramuscular, anatomical location: right deltoid, batch number: 1720701, expiry date: Apr-2018). It was reported that, the patient was administered two flu shots within the same year, with a month apart (explicitly coded as inappropriate schedule of vaccine administered). The reporter assessed this case as non-serious. Follow-up received on 19-Oct-2017: As per the reporter, at the time of report, the patient did not experience any adverse event (reported as the patient was fine).
Initial nurse report received on 07 Jul 2010: This patient received MENVEO (batch no: 100022) 0.5 ml dose intramuscularly on 06 Jul 2010. It was reported that the patient only received the diluent portion of MENVEO, rather than being reconstituted with the lyophilized powder. No adverse event was reported. The outcome of the event was not reported. The causality was not reported.
This spontaneous report as received from a pharmacist refers to an unspecified patients of unknown age and unknown gender. On an unknown date, the unspecified patients were vaccinated with doses of improperly stored GARDASIL 9. No adverse effects were reported. This is one of the several reports from the same reporter. Additional information has been requested.
Uncontrollable body shakes - like shivering from being really cold - for about an hour. It was severe and constant enough that I couldn?t stand because I was shaking so bad for only about 15 minutes, then it slowly tailed off and went away.
Vaccine administered after temperature excursion; Vaccine administered after temperature excursion/ vaccine administered after being frozen at 23 degree fahrenhiet; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) and PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion/ vaccine administered after being frozen at 23 degree fahrenhiet) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033F21A) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In November 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) and PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion/ vaccine administered after being frozen at 23 degree fahrenhiet). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) and PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion/ vaccine administered after being frozen at 23 degree fahrenhiet) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Reporter stated that 10 vials of 15 doses each were stored in a freezer which temperature range was at all times from 24.3°F to 24.7°F.  HCP mentioned that they always had the freezer between this range. Two vials were used to administered HCP's office employees. All doses were injected IM in deltoid muscle. Lot #033F21A. Exp. Date 08Apr2022.  Upon follow up it was reported that vaccine was administered after being frozen at 23 degrees Fahrenheit since receipt and did not had any adverse events.  Vaccine administration dates were reported as 23-Nov-2021 and 27-Nov-2021.  Further it was reported that vaccine could be used until expiration date.  Treatment medication was not provided by the reporter.   This case was linked to MOD-2022-474544 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Feb-2022: Follow up received contains Significant information-updated narrative
Information has been received from a nursing assistant referring to a patient of unknown age and gender. On 11-MAY-2015 the patient was inadvertently vaccinated with a dose of (Merck) VARIVAX (lot#, expiration date were unknown, 0.5 ml) subcutaneous which had been improperly stored (incorrect product storage). No adverse effects were reported. Additional information has been requested.
No additional adverse events reported.; a dose of GARDASIL 9 was administered during a temperature excursion; temperature 48.4F and 32.7F; This spontaneous report was received from a certified medical assistant and refers to 12-year-old patient of an unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 04-DEC-2020, the patient was vaccinated with an improperly stored dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) 0.5 ml, lot # S008153, expiration date 20-NOV-2021 (route of administration and anatomical location were not reported) for prophylaxis. The vaccine was administered during a temperature excursion, before the stability was known. Administered dose of the vaccine was stored in temperature of 48.4 degrees Fahrenheit (F) for 15 minutes and in temperature of 32.7 F for 47 hours. No previous temperature excursion occurred. Digital data logger was not involved.   No adverse events were reported. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S008153; expirationdate: 20-NOV-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Itchy, red, warm, spreading rash on around injection site.  Started Sunday, 9/12.  Still spreading on Thursday, 9/16.
He says he "felt like a truck hit me" for 2-3 days immediately after booster shot,  along with body aches and fatigue.    Then itching on hands, progressed to his forearms and legs and feet, without a rash, began mid January.     No history of itching or Allergies.    Allegra made it go away, but if he missed a dose of Allegra he will get recurrent itching within 1 day.   Denies other allergy symptoms.  This was persistent as of June 2022.
"Paralyzed waist down for 3 days" "Collapsed lung" currently 12/27/06-records received and reviewed from Dr. DX: serum sickness. Multiple joint deformity swelling and tenderness
I have had extremely strong headache consistently since first shot. I started bleeding 2 weeks before my period. It was full of blood clots and extremely heavy. I have felt light headed and tired since the vaccine. I get dizzy when i stand up often.
PATEINT RECEIVED THE VACCINATION ON 5/21/2021 AT 1330 HOURS. BY 5/22/2021 HE HAS REPORTED THAT HE HAS DEVELOPED PERIPHERAL NEUROPATHY IN BOTH OF HIS HANDS THAT HAS PROGRESSIVELY GOTTEN WORSE OVER THE LAST 6 DAYS. TODAY HIS HANDS HURT SO BAD THAT HE CAN HARDLE ZIP UP HIS PANTS AND CANNOT LIFT MOST OPTIONS. ANYTHING THAT PUTS ANY PRESSURE ON HIS FINGERS OR HANDS CAUSES PAIN.  AT THIS TIME, I AM GOING TO CONTACT HIS PHYSICIAN TO SEE IF INCREASING HIS GABAPENTIN WILL BE OF ANY BENEFIT AND IN THE MEANTIME WE ARE STARTING SCHEDULED APAP 1000 MG QID AND NAPROXEN 440 PO BID-TID UNTIL A PHYSICIAN CONSULT CAN BE MADE. CONDITION  DOES NOT APPEAR TO BE LIFE THREATENING AT THIS TIME, HOWEVER THE PATIENT IS EXTREMELY DISABLED AT THIS POIN AS USE OF EITHER HAND FOR COMPLETION OF DAILY ACTIVITES IS EXTEREMLY LIMITED.
He stated that normal range for him is between 80 & 90. The last three days it has gone up, yesterday he was at 200; This is a spontaneous report from Pfizer sponsored program Pfizer. A contactable consumer(patient). A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 25Mar2021 as SINGLE DOSE for covid-19 immunisation.  Medical history included diabetic. The patient's concomitant medications were not reported. The patient had his 1st dose 25Mar2021 and three days ago he was checking his sugars because he's diabetic. He stated that normal range for him is between 80 and 90. The last three days it has gone up, yesterday he was at 200. He stated he is on a glucose diet and doesn't eat carbs and was informed by his HCP that the Covid vaccine can cause sugars to go up within the first 48 hours. He stated well this has been more than 48 hours. He wants to know if this is part of the vaccine and if he should get his 2nd dose.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
was a previous VAERS because on 2/2/2021 Health Department had a administration error and gave this 17 year old a Moderna vaccine.  Family (Father) was notified and told that error had been made.    On  3/9/2021   Health Department saw update on  website dated 3/5/2021 with recommendations on what to do for a person who was too young to receive  Moderna.  Upon looking in our State Immunization Registry , , found that client had received a Pfizer Vaccine in another town in  at a .  Called  and spoke with Pharmacist.   Pharmacist on duty was unaware of updates on 3/5/2021 on website for Interim Clinical Considerations for COVID Vaccine.  Pharmacist on duty states she does not have access to  , State Immunization Registry to see what vaccines have previously been given.  Informed Pharmacist that   Health Department would submit a 2nd VARES on .  She will speak to the lead pharmacist  when he works next.
Nausea & vomiting 2 days after injection-Recovered by 3rd day.
3RD BOOSTER SHOT WAS GIVEN EARLIER THAN 6 MONTHS FROM THE SECOND SHOT.
Headache, fever, achy muscles, cough, fatigue.  Symptoms continued several days until Doctor prescribed a course of Amoxicillin on 3/8.  Today, 3/10, symptoms mainly gone.  Still have a slight fever and cough.
Some of the product leaked from where the needle was attached to the syringe; A spontaneous report was received from a nurse concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced some of the product leaked from where the needle was attached to the syringe, patient did not receive full dose.  The patient's medical history was not provided. Concomitant product use was not provided.  The patient received their first of two planned doses of mRNA-1273 (Lot number: not provided) on (date of vaccination not provided) for prophylaxis of COVID-19 infection.   A nurse called to report a vaccinator was pulling a dose to give to this patient and noticed some of the product leaked from where the needle was attached to the syringe. The nurse reported, patient did not receive a full dose.   Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The events, some of the product leaked from where the needle was attached to the syringe, patient did not receive full dose, was considered resolved.  The reporter did not provide an assessment of the events, some of the product leaked from where the needle was attached to the syringe, patient did not receive full dose.; Reporter's Comments: This report refers to a case of incorrect dose administered for mRNA-1273.  There were no reported adverse events associated with this case.
Chills; body aches; joint aches; fever (102.7 F); This is a spontaneous report from a contactable consumer reported for a patient. A 40-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: ER2613, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 21Apr2021 at 09:00 am (age at vaccination was 40 years) as dose 2, single for COVID-19 immunization. The patient did not have any medical history. The patient did not have any known allergies. The patient did not receive any concomitant medications or other medications in two weeks. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EJ1985, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 30Mar2021 at 09:15 am (age at vaccination was 40 years) as dose 1, single for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 21Apr2021 at 23:00 pm, the patient experienced chills, body aches, joint aches and fever (102.7 F). The patient underwent lab test which included body temperature: 102.7 Fahrenheit (Fever) on 21Apr2021. No treatment was received for the adverse events. The outcome of the events was not resolved.   No follow up attempts are possible. No further information is expected.
Metallic-foul taste in mouth.  Happened within 1 minute of injection.  Still ongoing.
1st dose on 12/31/2020.  Within 5 minutes of vaccine became severely dizzy, became briefly tachycardic with diffuse warmth and claminess.  EMS was called after it didn't resolve after 20-30 minutes.  Blood sugar 123.  BP was elevated to high 160's over high 90s.  EMS transported me to the ER.   1 liter of fluids given and BP was back to normal.   Head CT scan was done and was normal.  Dizziness persisted for about 6 hours and I was very tired for the rest of the day with achiness noted in the evening.  I was fine by the next day. 2nd dose received on 1/21/21.  I had only slight dizziness after that dose and was able to leave after 30 minutes observation time.  Was very tired the weekend following vaccine and have had periods of dizziness/nausea since Sunday1/24/2021.  I am still feeling dizzy and nauseated 1/27/21 and was encouraged to report possible side effect to the vaccine.
Rash and urticaria pruritus. Diphenhydramine 25 mg PRN.
Immediate heart pounding, facial flushing and tingling,  Doctor on duty came over and stayed with me for 30 minutes. She put devise in my finger that measures oxygen exchange and heart rate which was 105. She also got ice packs and a cold neck towel to put on. Gradually everything subsided, but I was unable to drive home so my husband did so. I developed a significant headache, so I went to bed when I arrived home.
A territory representative reported that she received an injection of tetanus toxoid (manufacturer unknown) and experienced injection site pain. The pain persisted as of 6/06/2000.
started my period 2 weeks early with large blood clots x 10 days with contraction like cramping.   this is abnormal for me as my period is very very light x 2-3 days.   next cycles started 5 days late again with large blood clots, contractions so bad i had to miss work.  cycles is on day 10 with continued large blood clots daily where i soil my clothing
Blurry vision, dizziness, severe headache and numb left leg and left arm, resulting in ER visit, hospitalization and diagnosis of ischemic stroke due to carotid artery dissection. Hospitalized and treated with anticoagulant medication. Currently undergoing outpatient physical, occupational and speech therapy.
come down with COVID; come down with COVID; This is a spontaneous report from a contactable consumer via a sales representative. This same consumer reported for 3 patients. This report is 1st of 3.  An elderly female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. No medical history and concomitant medications were reported. On an unspecified date, after use of Pfizer vaccine, the patient come down with COVID. Event took place after use of product. The event was serious (medically significant). The reporter who reported for 3 patients, stated that all of them took the Pfizer vaccine when it became available because they were over 75 years of age. Recently three out of the eight in the group had come down with COVID. Their strain was unknown. It was believed that all were over 75 years old with co morbidities, and female. One of them had lost their husband to COVID unknown if he had been vaccinated. The patient underwent lab test which included SARS-CoV-2 test: Positive on an unspecified date. The outcome of the event was unknown.  Information about batch/lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021873318 Different patients, Same reporter, vaccine, event.;US-PFIZER INC-2021873319 Different patients, Same reporter, vaccine, event.
His symptoms were Lyme disease and kind of deteriorated after that. He had one episode of one day where he lost his taste. I was told by the doctors he has cancer and hospitalized in October 2022 for dehydration and bloody stools.  He was so weak, had headache, dizziness and anorexia and was unable to eat and balance problems.  Before this he was extremely healthy and after his vaccine his health deteriorated. He also had chemo and radiation in January through April 2023.  He had MRI and scans from his head to his pelvis and also CT scans.  At this time he is still recovering from his symptoms. He also has been tested for COVID-19, several tests have been negative.
Symptoms the following day:  9/10 headache, all over body aches, nausea, dizziness, fatigue, urinary retention.  The day after that I woke up with a skin reaction (red, blotchy) on my neck, chest, back, upper abdomen, and itching across my upper back.
I woke up the next morning with the usual symptoms fatigue, aches. An hour later when I got a call I realized my voice had changed. Two weeks later I had an annual physical and that is when I talked to my doctor about this. He gave me steroids, and he said it would clear it up but it made no difference at all. So I called back, and they got me into see an ENT. The ENT is Dr. he did the nasal laryngoscopy and said my  left vocal cord is paralyzed. He said there is nothing they could do except to go to speech therapy if I wanted to.  I was told that my voice might come back eventually.
pt tested positive for COVID on 9/1; presented to ED with chills and SOB, placed on BIPAP, had several episodes of ventricular tachycardia; appeared to be stable on BIPAP but had several episodes of ventricular tachycardia which led to ventricular fibrillation; pt became hypotensive; 30mins of ACLS, epinephrine drip, and intubation  didn't establish circulation, pt died in the hospital
swollen, tender axillary node- on right side of chest noticed day after first vaccine and is still experiencing, also a fever that began last night (one night after first vaccine) - which is also still present.
A report has been received from a Health Professional concerning a 2 year old female patient. No medical history, concurrent diseases and concomitant medications were reported. On 16-Oct-2012, the patient received nasal FLUMIST. The patient's test was positive for influenza A on 15-Dec-2012. Patient was treated with TAMIFLU. The outcome of the event of tested positive for influenza A was recovered. The report was considered to be non-serious by the reporter. Summary of follow-up information received by AstraZeneca/MedImmune 24-Jan-2013 from Health Professional: Event outcome was updated from unknown to recovered. Patient reporter deleted. Reporter's details updated. Patient detail added. County of administration was added. Lab detail added. Corrected report 29-Jan-2013: Action taken corrected from Unknown to Not applicable. Associated case ID added.
Patient was injected with an unused, empty retractable syringe. The syringe was just filled with air and she had no reaction at the time of injection.
This spontaneous report as received from a Medical Assistant refers to multiple unspecified patients of unkonwn age and gender. On an unknown date, the patients were vaccinated with improperly stored VAQTA Lot # J000366, expiration date 22-AUG-2015, Lot # K000943, expiration date 24-SEP-2016 and Lot #J011757, expiration date 15-JAN-2016 (reported as 13-JAN-2016) (dose and route were not reported). No adverse effects reported. No quality product complaint (PQC) was reported. This is one of several report received from the same report. Additional information has been medical.
Second day tired and head ache  3rd and 4th day i felt good Friday tired and tight chest,  continued on Saturday  Woke up sunday after sleeping 14 hours straight   tight chest and head ache continues   Monday headache and tight chest and pain onleft side of upper chest.
Less than 24h after vaccination, patient experienced progressive swelling, induration, red blotchy rash, and pain at R upper extremity around injection side. Swelling and pain continued down arm, with sensation of swelling and pain into hand and into the R neck.